. Author manuscript; available in PMC: 2014 Jun 8.

Published in final edited form as: Int J Immunopathol Pharmacol. 2011 Apr-Jun;24(2):489–497. doi: 10.1177/039463201102400222

Table III.

Relative changes separately for acetylation and methylation (The values in parentheses indicate the percentages of changes in non-recurrent and recurrent PUNLMP and UC in relation to NU)

	Diagnostic groups

	NU	NR PUNLMP	R PUNLMP	UC
Nuclei in basal position

Acetylation	100%	95% (− 5%)	85% (− 15%)	76% (− 24%)

Methylation	100%	105% (+ 5%)	81% (− 19%)	161% (+ 61%)

Nuclei in intermediate position

Acetylation	100%	116% (+ 16%)	98% (− 2%)	99% (− 1%)

Methylation	100%	105% (+ 5%)	85% (− 15%)	141% (+ 41%)

Nuclei in superficial position

Acetylation	100%	125% (+ 25%)	106% (+ 6%)	NA^*

Methylation	100%	99% (− 1%)	76% (− 24%)	NA^*

See footnote of Table 1